leniolisib

1. Introduction & Mechanism of Action of Joenja Joenja is an oral, targeted therapeutic agent containing leniolisib phosphate, utilized for the treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome, a rare genetic immunodeficiency disorder. Its most notable clinical side effects include recurring headaches, frequent sinusitis, and mild to moderate gastrointestinal distress, primarily presenting as diarrhea. Leniolisib … Read more